Halozyme Therapeutics, Inc.

VANGUARD GROUP INC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

11,566,896

Value ($000)

778,452

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	778,452	0.0%	11,566,896	12/31/2025
2025 Q3	11/7/2025	852,929	0.0%	11,629,786	9/30/2025
2025 Q2	8/11/2025	637,016	0.0%	12,245,602	6/30/2025
2025 Q1	5/9/2025	818,778	0.0%	12,831,503	3/31/2025
2024 Q4	2/11/2025	634,999	0.0%	13,281,714	12/31/2024
2024 Q3	11/13/2024	738,115	0.0%	12,895,096	9/30/2024
2024 Q2	8/13/2024	674,473	0.0%	12,881,459	6/30/2024
2024 Q1	5/10/2024	530,844	0.0%	13,049,253	3/31/2024
2023 Q4	3/11/2024	490,072	0.0%	13,259,514	12/31/2023
2023 Q3	12/18/2023	500,674	0.0%	13,106,644	9/30/2023
2023 Q2	8/14/2023	473,825	0.0%	13,136,265	6/30/2023
2023 Q1	7/14/2023	516,315	0.0%	13,519,639	3/31/2023
2022 Q4	2/10/2023	756,989	0.0%	13,303,847	12/31/2022
2022 Q3	11/14/2022	527,273	0.0%	13,335,155	9/30/2022
2022 Q2	8/12/2022	585,061	0.0%	13,296,813	6/30/2022
2022 Q1	5/13/2022	528,407	0.0%	13,249,920	3/31/2022
2021 Q4	2/14/2022	542,670	0.0%	13,495,913	12/31/2021
2021 Q3	11/12/2021	554,296	0.0%	13,625,741	9/30/2021
2021 Q2	8/13/2021	619,315	0.0%	13,638,304	6/30/2021
2021 Q1	5/14/2021	552,721	0.0%	13,257,866	3/31/2021
2020 Q4	2/12/2021	561,625	0.0%	13,149,703	12/31/2020
2020 Q3	11/16/2020	334,477	0.0%	12,727,416	9/30/2020
2020 Q2	8/14/2020	349,806	0.0%	13,047,599	6/30/2020
2020 Q1	5/15/2020	250,029	0.0%	13,898,214	3/31/2020
2019 Q4	2/14/2020	248,277	0.0%	14,003,155	12/31/2019
2014 Q2	8/11/2014	60,816	0.0%	6,155,526	6/30/2014
2014 Q1	5/13/2014	78,132	0.0%	6,152,087	3/31/2014
2013 Q4	2/12/2014	79,072	0.0%	5,275,026	12/31/2013